The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir

Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) (NIH)
Overall Status
Completed
CT.gov ID
NCT00000898
Collaborator
(none)
18
4
4.5

Study Details

Study Description

Brief Summary

The purpose of this study is to see if staggering doses of nelfinavir, ritonavir, and saquinavir has any effect on the interactions between these drugs.

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Primary Purpose:
Treatment
Official Title:
A Prototype Study to Test the Effect of Staggered Dosing on the Pharmacokinetic Interactions Between Paired Combinations of Nelfinavir (NFV), Ritonavir (RTV), and Soft Gelatin Capsule of Saquinavir (SQVsgc)
Actual Study Completion Date :
May 1, 2000

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes

    Inclusion Criteria

    Patients must have:
    • Absence of HIV-1 infection as documented by any licensed ELISA test kit within 14 days prior to study entry.

    Exclusion Criteria

    Co-existing Condition:
    Patients with the following symptoms and conditions are excluded:
    • Any medical condition that, in the opinion of the investigator, would interfere with the patient's ability to participate in this protocol.
    Patients with the following prior conditions and symptoms are excluded:
    • History of chronic illness such as hypertension, coronary artery disease, arthritis, diabetes, or any chronic gastrointestinal conditions that might interfere with drug absorption.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 San Francisco Gen Hosp San Francisco California United States 941102859
    2 Univ of California/ San Francisco / Dept of Medicine San Francisco California United States 94110
    3 Stanford Univ Med Ctr Stanford California United States 943055107
    4 Johns Hopkins Hosp Baltimore Maryland United States 21287

    Sponsors and Collaborators

    • National Institute of Allergy and Infectious Diseases (NIAID)

    Investigators

    • Study Chair: Blaschke T,
    • Study Chair: Flexner C,
    • Study Chair: Sheiner L,

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    National Institute of Allergy and Infectious Diseases (NIAID)
    ClinicalTrials.gov Identifier:
    NCT00000898
    Other Study ID Numbers:
    • ACTG 378
    • 11339
    First Posted:
    Aug 31, 2001
    Last Update Posted:
    Oct 29, 2021
    Last Verified:
    Oct 1, 2021
    Keywords provided by National Institute of Allergy and Infectious Diseases (NIAID)
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 29, 2021